Ribon Therapeutics

Ribometrix

The company develops small molecule therapeutics targeting RNA structures to treat human diseases for pharmaceutical partners and patients with cancer or neurodegenerative conditions.

Redona Therapeutics

This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.

Accent Therapeutics

This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

Tipping Point Biosciences

This biotechnology company develops a drug discovery platform and small molecule therapies targeting dysfunctional DNA packaging for patients with cancer and neurodegenerative diseases.

Endeavor BioMedicines

This clinical-stage biotechnology company develops small-molecule inhibitors and therapies for patients with oncology and fibrotic lung diseases.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.